Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-01-17
1990-04-03
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
049141074
ABSTRACT:
This invention relates to the use in vivo of 1-isopropyldihydrolysergic acid as a 5-HT.sub.2 antagonist.
REFERENCES:
patent: 3580916 (1971-05-01), Garbrecht
patent: 3904634 (1975-09-01), Arcari et al.
patent: 4491664 (1985-01-01), Oppolzer
patent: 4714704 (1987-12-01), Garbrecht et al.
patent: 4734501 (1988-03-01), Marzoni
Cohen et al., J. Pharm. Exp. Therap. 244, 106-112 (1988).
Cohen Marlene L.
Goldberg Mark J.
Lemberger Louis
Eli Lilly and Company
Friedman Stanley J.
Jones Joseph A.
Martens William C.
Whitaker Leroy
LandOfFree
Method for selectively blocking 5-HT.sub.2 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for selectively blocking 5-HT.sub.2 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for selectively blocking 5-HT.sub.2 receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1357796